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Side-alternating vibration training (SAVT) was used for 15 weeks in a patient with Late-onset Pompe disease who had never used
enzyme replacement or chaperone therapy. Prior to the use of SAVT, the patient had experienced declining muscle performance
and her 6-minute walk distance decreased from 210 to 155 metres in 6 months. After SAVT, her 6-minute walk distance increased
70% from 166 to 282 metres, muscle jumping power increased by 64% from 83 to 166watts, isometric knee extensor strength
increased 17% from 38 to 44Nm, and she achieved a more normal pattern of ankle, knee, and joint kinematics and kinetics.
Her functional ability measured through the Rotterdam 9-item score was unchanged at 19/36. There were no elevations in serum
creatine kinaseor lactate. This isthe ﬁrstreport,toour knowledge, of aperformance improvement ina patient with Pompe disease
using SAVT.
Copyright © 2009 Aneal Khan et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Late-Onset Pompe disease (acid alpha-glucosidase deﬁ-
ciency, OMIM 606800) can lead to progressive muscle weak-
ness and loss of mobility [1]. Many patients further develop
deconditioning from decreased physical activity which com-
pounds the declining muscle function. Side-alternating
vibration training (SAVT) has been used to improve postural
stability, muscle strength, and overall muscle performance in
healthy subjects and athletes [2–6]. To our knowledge, the
use of SAVT has not been previously reported in patients
with a progressive myopathy such as late-onset Pompe
disease (LOPD). We report the results of 15 weeks of SAVT
in a patient with LOPD and no prior use of enzyme replace-
ment or chaperone therapy who was experiencing declining
ambulatory function. We suggest that other patients with
late-onset Pompe disease may also beneﬁt from SAVT.
2.CaseReport
Our patient was a 34-year-old woman who was diagnosed at
30 years of age with late-onset Pompe disease. Sequencing
of the GAA gene (Dr. Nancy Carson, Children’s Hospital
of Eastern Ontario) showed a c.-32-13 T > Ga n da
c.2481 + 102 2646 + 31 deletion of intron 1 and introns
17 to 18, respectively. Her T-cell alpha-glucosidase activity
was <2.5nmol/h/mg protein (controls 28.3–66.2) (Dr. Floyd
Snyder, University of Calgary). She had never used enzyme
replacement therapy or any other form of drug therapy
targeted to acid alpha-glucosidase deﬁciency. She was ambu-
latory but walked slowly, and required a cane in the months
prior to using SAVT, had diﬃculty ascending or descending
roadside curbs, and was unable to stand from a sitting posi-
tion without the use of aids. She reported chronic weakness
and fatigue resulting in diﬃculty using stairs. Additionally,
she noted an accelerated decrease in her physical abilities
over the last two years with the need to reduce the number
of hours she was working. She never required ventilatory
support and had normal cardiac function.
Baseline investigations included the Rotterdam 9-item
scale [7], 6-minute walk test (6MWT), grip strength (Base-
line Hydraulic Dynamometer, White Plains, NY, USA), iso-
metric hamstrings and quadriceps strength (Biodex System2 Case Reports in Medicine
3 Pro, Biodex Medical Systems, Inc., NY, USA), peak lower
extremity power using a force plate (Advance Mechanical
Technology Inc. (AMTI), Watertown, MA, USA), custom-
written software (MATLAB, MathWorks, Natick, MA, USA),
lower extremity 3D kinematics and kinetics during level
walking (Motion Analysis Corp, Santa Rosa, Calif, USA;
AMTI, Watertown MA, USA), serum creatine kinase, urine
24 hour myoglobin, and serum electrolytes. She was started
on a protocol using a side-alternating vibration plat-
form (Vibraﬂex, Galileo, Home Edition, Novotec Medical,
Pforzheim, Germany). Each SAVT session comprised 60
seconds vibration-on then 60 seconds vibration-oﬀ sequence
(one cycle), starting with two cycles initially, progressing
to four cycles by week 11 and continuing with four cycles
to week 15. Initially, the vibration frequency was 5Hz,
progressing to 20Hz by week 11 and continuing at 20Hz
to week 15. Her stance was similar for all sessions with each
hallux positioned 11cm from the vibration axis and knees
and hips slightly ﬂexed. The subject was 100% compliant
with 3 sessions per week for a total of 15 weeks. Follow-up
measurements were made 5 days after her last SAVT session.
Mean grip strength was calculated from 3 trials using each
hand separately and served as an internal control of muscle
function.
3. Results
3.1. Tolerance to SAVT. The SAVT was generally well toler-
ated. The following symptoms were reported as a percentage
of total vibration sessions: muscle discomfort (soreness,
stiﬀness, aches) in the legs (49%), twitching while at rest
(31%), cramping (2%), and fatigue (4%). Most often,
these symptoms occurred the day following SAVT would
be aggravated by longer days at work and caused minor
discomfort but did not cause the patient to change her
activity level. Other than the muscle twitching, she did not
feel that these symptoms had worsened compared to her
baseline and generally improved with massage therapy.
There was no change in her weight, blood pressure,
resting heart rate, serum creatine kinase, or 24 hour urine
myoglobin (Table 1). Venous blood lactate measured mid-
way and at the end of the trial were 1.7mmol/L and
1.2mmol/L, respectively, (normal).
3.2. Muscle Performance. After showing an initial decline
in her 6-minute walk test (6MWT) prior to commencing
SAVT,thepatientshoweda70%improvementinthedistance
traveled, from 166 to 282 metres after using SAVT (Figure 1).
Peak lower extremity power using jumping mechanography
improved by 64% from 83 to 136 watts. Isometric strength
of the knee extensors increased 17% (from 38 to 44Nm)
while ﬂexor strength diminished 13% (from 15 to 13Nm).
During this time period, mean grip strength was unchanged
(left hand 17.7 to 18.5kg (39.0 to 40.8lb), right hand 18.3 to
18.8kg (40.3 to 41.5lb)). At week 4 of SAVT she no longer
used a cane during walking. At week 14 of SAVT she was able
to bend her knees without falling and able to lift her right
leg oﬀ the bed. Functional abilities assessed using a 9-item
Rotterdam scale were unchanged at 19/36.
Table 1: Baseline and post-SAVT physical parameters and bio-
chemistry data.
Baseline Post-SAVT
Weight (kg) 60 60
Resting heart rate (beats per minute) 79 84
Systolic blood pressure (mmHg) 111 119
Diastolic blood pressure (mmHg) 73 87
Serum creatine kinase (U/L) 1080 1060
Serum creatinine (umol/L) 41 34
24 hour urine myoglobin excretion negative negative
Table 2: Baseline and post-SAVT muscle strength.
Baseline Post-SAVT
Hip ﬂexion 2+ 3−
Hip extension 2− 3−
Hip abduction 2− 3−
Knee ﬂexion 4− 4
Knee extension 3+ 3+
Ankle dorsiﬂexion 4+ 5
Ankle inversion 5 5
Modiﬁed Medical Research Council scale: 5 = completes movement through
full range of motion (ROM) against gravity with maximal resistance; 4 =
full ROM against gravity with moderate resistance; 3 = full ROM against
gravity;2=fullROMwithgravityeliminated.Thequaliﬁers+and–indicate
the amount of ROM the patient is able to complete within each level of
resistance.
Manual muscle testing (MMT) was completed by the
same therapist at baseline and post-SAVT (Table 2) using a
modiﬁed Medical Research Council (MRC) scale [8]. Right
and left legs demonstrated the same strength, and all muscles
showed improvement except knee extensors which were
similar pre- and post-SAVT.
During level walking at a self-selected speed, hip,
knee, and ankle joint kinematics and kinetics improved
dramatically between the pre- and post-SAVT intervention,
with a pattern of greater improvement distally (ankle) than
proximally (hip) (Figure 2). The ankle joint demonstrated
greater overall excursion, particularly early and late in
the gait cycle. Knee hyperextension during stance (right
heel strike to right toe-oﬀ) persisted after SAVT, but knee
excursion during the swing phase (right toe-oﬀ to right
heel strike) improved after intervention. Temporally, the hip
improved with joint angle at heel strike and in late swing
falling within the normal range. Based on the Gillette Gait
Deviation Index [9], her right leg improved from a value of
73.0to82.8, andherleftlegimproved from70.1to85.7, with
100 being a normal median score.
There was no change in pulmonary status or forced vital
capacity (FVC) in the patient over the course of vibration
training.
4. Discussion
Conventional methods of improving muscle performance
use resistance and endurance training. Many patients withCase Reports in Medicine 3
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Figure 1: Muscle measurements before SAVT (April 21, 2007 to
April20,2008)andafterSAVT(startedonApril21,2008).Calendar
date is along the x-axis and numerical measurements along the y-
axis for peak power (watts), six-minute walk test distance (6MWT;
metres), left mean grip strength (LMGS; pounds), and right mean
grip strength (RMGS; pounds).
late-onset Pompe disease report decreased motivation for
exercise because of muscle weakness, generalized fatigue,
shortness of breath, and a higher level of eﬀort required. To
compound the underlying myopathy, the inactivity further
deteriorates muscle function through deconditioning. Even
in healthy subjects, deconditioning can lead to loss of muscle
bulk and performance [10, 11].
Vibration is a mechanical oscillation characterized by
amplitude (mm) and frequency (Hz) which is applied
indirectly to muscles through the joints while standing on a
vibrating platform [12]. The vibration is transmitted from
the platform through the muscles of the leg and hips [2–
4, 13, 14]. Vibration was initially used in conjunction with
exercisefortrainingathletestoimproveperformance[13,15]
andasacounter-measuretoreducetheimpactofspace-ﬂight
on muscle performance and bone health [16]. Therefore,
we felt there was potential for its application in mobility-
impaired patients with weakness from Pompe disease.
The 6MWT is a standard clinical measure of walking
performance [17]. The improvement in the 6MWT in our
patient is similar in distance, greater when measured in
relative amounts, to the eﬀects of strength training and
cardiovascular exercise in women with ﬁbromyalgia [18]
and better than self-administered exercise programs in the
elderly [19]. Muscle power using jump mechanography has
a high degree of correlation with the chair rising manouvre
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Figure 2: Normalized sagittal kinematics for the right hip, knee,
and ankle joints for the pre- (dashed line) and post-SAVT
(solid line) trials. Age-matched normal data (mean ± 1S D )a r e
represented by the gray band. The x-axis is normalized stride cycle,
with right heel strike (RHS) occurring at 0% of the cycle, followed
by left toe-oﬀ (LTO), left heel strike (LHS), right toe-oﬀ (RTO), and
RHS. The y-axes are the joint angles (degrees) with the zero line
representing neutral joint position. The same ﬁndings were noted
on the left side.4 Case Reports in Medicine
and in patients who are not able to get up from a chair
without considerable assistance, such as in our patient and
other patients with Pompe disease, improvements in this
activity are functionally very important [20]. Our patient
showed a greater improvement in peak power using jumping
mechanography compared to healthy subjects who had
received a 4-month trial of SAVT [3]. Furthermore, there
were dramatic improvements in gait kinetics and kinematics,
particularly distally, and in a clinical index of overall
gait function. Equally important, there were no functional
declines in performance using the Rotterdam 9-item scale.
The results from our single case report show that SAVT
can be tolerated by patients with late-onset Pompe disease
andmayimprovemusclefunctionandwalking.Wefeelthere
ispotentialforusingSAVTinpatientswithlate-onsetPompe
disease and impaired mobility. Whether there is a general
beneﬁt to patients and improved performance of activities
of daily living will require clinical trials of longer duration
involving more subjects.
References
[ 1 ]L .P .F .W i n k e l ,M .L .C .H a g e m a n s ,P .A .v a nD o o r n ,e ta l . ,
“The natural course of non-classic Pompe’s disease; a review
of 225 published cases,” Journal of Neurology, vol. 252, no. 8,
pp. 875–884, 2005.
[2] S. Torvinen, P. Kannus, H. Siev¨ anen, et al., “Eﬀect of
a vibration exposure on muscular performance and body
balance. Randomized cross-over study,” Clinical Physiology
and Functional Imaging, vol. 22, no. 2, pp. 145–152, 2002.
[3] S. Torvinen, P. Kannus, H. Siev¨ anen, et al., “Eﬀect of four-
month vertical whole body vibration on performance and
balance,” Medicine & Science in Sports & Exercise, vol. 34, no.
9, pp. 1523–1528, 2002.
[4] S. Torvinen, P. Kannus, H. Siev¨ anen, et al., “Eﬀect of 8-month
vertical whole body vibration on bone, muscle performance,
and body balance: a randomized controlled study,” Journal of
Bone and Mineral Research, vol. 18, no. 5, pp. 876–884, 2003.
[ 5 ] J .R i t t w e g e r ,G .B e l l e r ,a n dD .F e l s e n b e r g ,“ A c u t ep h y s i o l o g i c a l
eﬀects of exhaustive whole-body vibration exercise in man,”
Clinical Physiology, vol. 20, no. 2, pp. 134–142, 2000.
[6] S. S. Rees, A. J. Murphy, and M. L. Watsford, “Eﬀects of whole
body vibration on postural steadiness in an older population,”
Journal of Science and Medicine in Sport. In press.
[ 7 ]M .L .C .H a g e m a n s ,L .P .F .W i n k e l ,P .A .v a nD o o r n ,e t
al., “Clinical manifestation and natural course of late-onset
Pompe’s disease in 54 Dutch patients,” Brain, vol. 128, no. 3,
pp. 671–677, 2005.
[8] J. M. Florence, S. Pandya, W. M. King, et al., “Intrarater
reliability of manual muscle test (Medical Research Council
scale) grades in Duchenne’s muscular dystrophy,” Physical
Therapy, vol. 72, no. 2, pp. 115–122, 1992.
[ 9 ]M .H .S c h w a r t za n dA .R o z u m a l s k i ,“ T h eg a i td e v i a t i o n
index: a new comprehensive index of gait pathology,” Gait and
Posture, vol. 28, no. 3, pp. 351–357, 2008.
[10] Y. Kawakami, Y. Muraoka, K. Kubo, Y. Suzuki, and T.
Fukunaga, “Changes in muscle size and architecture following
20 days of bed rest,” Journal of Gravitational Physiology, vol. 7,
no. 3, pp. 53–59, 2000.
[11] A. LeBlanc, P. Gogia, V. Schneider, J. Krebs, E. Schonfeld,
and H. Evans, “Calf muscle area and strength changes after
ﬁve weeks of horizontal bed rest,” American Journal of Sports
Medicine, vol. 16, no. 6, pp. 624–629, 1988.
[ 1 2 ]K .W a r d ,C .A l s o p ,J .C a u l t o n ,C .R u b i n ,J .A d a m s ,a n dZ .
Mughal, “Low magnitude mechanical loading is osteogenic
in children with disabling conditions,” Journal of Bone and
Mineral Research, vol. 19, no. 3, pp. 360–369, 2004.
[13] C. Delecluse, M. Roelants, and S. Verschueren, “Strength
increase after whole-body vibration compared with resistance
training,” Medicine & Science in Sports & Exercise, vol. 35, no.
6, pp. 1033–1041, 2003.
[14] J. Rittweger, M. Mutschelknauss, and D. Felsenberg, “Acute
changes in neuromuscular excitability after exhaustive whole
body vibration exercise as compared to exhaustion by squat-
ting exercise,” Clinical Physiology and Functional Imaging, vol.
23, no. 2, pp. 81–86, 2003.
[15] N. N. Mahieu, E. Witvrouw, D. Van de Voorde, D. Michilsens,
V. Arbyn, and W. Van den Broecke, “Improving strength and
postural control in young skiers: whole-body vibration versus
equivalentresistancetraining,”JournalofAthleticTraining,vol.
41, no. 3, pp. 286–293, 2006.
[16] A. Pavy-Le Traon, M. Heer, M. V. Narici, J. Rittweger,
a n dJ .V e r n i k o s ,“ F r o ms p a c et oE a r t h :a d v a n c e si nh u m a n
physiology from 20 years of bed rest studies (1986–2006),”
European Journal of Applied Physiology, vol. 101, no. 2, pp.
143–194, 2007.
[17] U.-B. Flansbjer, A. M. Holmb¨ ack, D. Downham, C. Patten,
and J. Lexell, “Reliability of gait performance tests in men and
women with hemiparesis after stroke,” Journal of Rehabilita-
tion Medicine, vol. 37, no. 2, pp. 75–82, 2005.
[18] D. S. Rooks, C. B. Silverman, and F. G. Kantrowitz, “The
eﬀects of progressive strength training and aerobic exercise
on muscle strength and cardiovascular ﬁtness in women with
ﬁbromyalgia: a pilot study,” Arthritis Care and Research, vol.
47, no. 1, pp. 22–28, 2002.
[19] M. B. King, R. H. Whipple, C. A. Gruman, J. O. Judge, J. A.
Schmidt, and L. I. Wolfson, “The performance enhancement
project: improving physical performance in older persons,”
Archives of Physical Medicine and Rehabilitation, vol. 83, no.
8, pp. 1060–1069, 2002.
[20] J. Rittweger, I. Michaelis, M. Giehl, P. W¨ usecke, and D.
Felsenberg, “Adjusting for the partial volume eﬀect in cortical
bone analyses of pQCT images,” Journal of Musculoskeletal
Neuronal Interactions, vol. 4, no. 4, pp. 436–441, 2004.